HEADER TRANSFERASE 09-JUN-05 1ZYD TITLE CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: WILD-TYPE TITLE 2 COMPLEXED WITH ATP. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE GCN2; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.1.37; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: GCN2, AAS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET26B KEYWDS TRANSLATION REGULATOR, PROTEIN KINASE, SIGNAL TRANSDUCTION, AMINO- KEYWDS 2 ACID STARVATION, STARVATION STRESS RESPONSE, EIF2ALPHA KINASE, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.K.PADYANA,H.QIU,A.ROLL-MECAK,A.G.HINNEBUSCH,S.K.BURLEY REVDAT 5 03-FEB-21 1ZYD 1 AUTHOR JRNL REMARK SEQADV REVDAT 5 2 1 LINK REVDAT 4 02-AUG-17 1ZYD 1 SOURCE REVDAT 3 24-FEB-09 1ZYD 1 VERSN REVDAT 2 16-AUG-05 1ZYD 1 JRNL REVDAT 1 21-JUN-05 1ZYD 0 JRNL AUTH A.K.PADYANA,H.QIU,A.ROLL-MECAK,A.G.HINNEBUSCH,S.K.BURLEY JRNL TITL STRUCTURAL BASIS FOR AUTOINHIBITION AND MUTATIONAL JRNL TITL 2 ACTIVATION OF EUKARYOTIC INITIATION FACTOR 2{ALPHA} PROTEIN JRNL TITL 3 KINASE GCN2 JRNL REF J.BIOL.CHEM. V. 280 29289 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15964839 JRNL DOI 10.1074/JBC.M504096200 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,MOLECULAR REMARK 3 : SIMULATIONS (BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1390079.250 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 18323 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.200 REMARK 3 FREE R VALUE TEST SET COUNT : 762 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 18600 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.92 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2675 REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.033 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4312 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 68 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.57000 REMARK 3 B22 (A**2) : -15.06000 REMARK 3 B33 (A**2) : 13.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.56 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.170 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.410 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.270 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 37.91 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ATP_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : &_1_TOPOLOGY_INFILE_2 REMARK 3 TOPOLOGY FILE 3 : &_1_TOPOLOGY_INFILE_3 REMARK 3 TOPOLOGY FILE 4 : ATP_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ZYD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUN-05. REMARK 100 THE DEPOSITION ID IS D_1000033264. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : DIAMOND 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18366 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.65000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP, CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 1ZXE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, CHES, PH 9.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 41.05500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 87.60500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.05500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 87.60500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY OF GCN2 PROTEIN KINASE IS A DIMER. REMARK 300 THE ASYMMETRIC UNIT OF THIS CRYSTAL LATTICE CONTAINS ONE DIMER REMARK 300 ASSEMBLED INTO ONE BIOLOGICAL UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 773 REMARK 465 PRO A 774 REMARK 465 MET A 775 REMARK 465 THR A 776 REMARK 465 ALA A 777 REMARK 465 VAL A 778 REMARK 465 ASN A 859 REMARK 465 VAL A 860 REMARK 465 HIS A 861 REMARK 465 ARG A 862 REMARK 465 SER A 863 REMARK 465 LEU A 864 REMARK 465 ASP A 865 REMARK 465 ILE A 866 REMARK 465 LEU A 867 REMARK 465 LYS A 868 REMARK 465 LEU A 869 REMARK 465 ASP A 870 REMARK 465 SER A 871 REMARK 465 GLN A 872 REMARK 465 ASN A 873 REMARK 465 LEU A 874 REMARK 465 PRO A 875 REMARK 465 GLY A 876 REMARK 465 SER A 877 REMARK 465 SER A 878 REMARK 465 ASP A 879 REMARK 465 ASN A 880 REMARK 465 LEU A 881 REMARK 465 THR A 882 REMARK 465 SER A 883 REMARK 465 ALA A 884 REMARK 465 LEU A 997 REMARK 465 VAL B 772 REMARK 465 LYS B 773 REMARK 465 PRO B 774 REMARK 465 MET B 775 REMARK 465 THR B 776 REMARK 465 ALA B 777 REMARK 465 VAL B 778 REMARK 465 LYS B 779 REMARK 465 LYS B 780 REMARK 465 LYS B 858 REMARK 465 ASN B 859 REMARK 465 VAL B 860 REMARK 465 HIS B 861 REMARK 465 ARG B 862 REMARK 465 SER B 863 REMARK 465 LEU B 864 REMARK 465 ASP B 865 REMARK 465 ILE B 866 REMARK 465 LEU B 867 REMARK 465 LYS B 868 REMARK 465 LEU B 869 REMARK 465 ASP B 870 REMARK 465 SER B 871 REMARK 465 GLN B 872 REMARK 465 ASN B 873 REMARK 465 LEU B 874 REMARK 465 PRO B 875 REMARK 465 GLY B 876 REMARK 465 SER B 877 REMARK 465 SER B 878 REMARK 465 ASP B 879 REMARK 465 ASN B 880 REMARK 465 LEU B 881 REMARK 465 THR B 882 REMARK 465 SER B 883 REMARK 465 ALA B 884 REMARK 465 LYS B 984 REMARK 465 HIS B 985 REMARK 465 GLN B 986 REMARK 465 ASP B 987 REMARK 465 GLU B 988 REMARK 465 VAL B 989 REMARK 465 ILE B 990 REMARK 465 LYS B 991 REMARK 465 GLU B 992 REMARK 465 ALA B 993 REMARK 465 LEU B 994 REMARK 465 LYS B 995 REMARK 465 SER B 996 REMARK 465 LEU B 997 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL A 772 O HOH A 73 2.18 REMARK 500 OE1 GLU A 954 O HOH A 62 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASN B 949 OD1 ASN B 949 2555 2.09 REMARK 500 OG1 THR A 899 O HOH A 1 1554 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN B 770 N - CA - C ANGL. DEV. = 18.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 622 19.71 53.47 REMARK 500 HIS A 632 -177.48 -170.35 REMARK 500 ASN A 770 -5.39 53.05 REMARK 500 PHE A 771 105.60 -23.42 REMARK 500 ASN A 804 46.33 38.26 REMARK 500 ARG A 809 -39.70 -34.47 REMARK 500 ASP A 835 51.05 -157.94 REMARK 500 LYS A 850 90.49 -160.93 REMARK 500 ASN A 903 -167.52 -127.83 REMARK 500 PRO A 943 150.03 -49.55 REMARK 500 ASP A 947 98.31 -48.52 REMARK 500 PRO A 982 -176.20 -57.52 REMARK 500 LEU A 994 -75.49 -65.69 REMARK 500 LYS A 995 33.46 -66.14 REMARK 500 ASP B 621 12.82 -145.54 REMARK 500 SER B 622 10.74 52.82 REMARK 500 HIS B 632 -179.13 -178.95 REMARK 500 ASN B 651 87.84 -167.56 REMARK 500 ARG B 769 28.02 -79.37 REMARK 500 ASN B 770 79.32 61.62 REMARK 500 ASP B 835 36.39 -155.60 REMARK 500 ARG B 847 36.87 74.12 REMARK 500 LYS B 850 81.76 -154.68 REMARK 500 VAL B 895 -66.37 -94.55 REMARK 500 LEU B 896 -20.04 -36.60 REMARK 500 GLU B 904 -9.86 -56.75 REMARK 500 ILE B 940 81.91 47.38 REMARK 500 ASN B 949 -50.44 -121.01 REMARK 500 HIS B 964 -7.34 -58.53 REMARK 500 PRO B 982 178.37 -58.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 ATP 303, MG 305, AND MG 306 ARE ASSOCIATED WITH PROTEIN CHAIN A REMARK 600 ATP 304, MG 307, AND MG 308 ARE ASSOCIATED WITH PROTEIN CHAIN B REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 305 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP A 303 O2G REMARK 620 2 ATP A 303 O3B 50.8 REMARK 620 3 ATP A 303 O3G 51.6 52.4 REMARK 620 4 ATP A 303 O1A 93.6 66.6 118.9 REMARK 620 5 ASP A 853 OD1 160.6 109.8 119.5 75.7 REMARK 620 6 ASP A 853 OD2 113.2 67.1 73.4 81.2 49.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 306 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP A 303 O3B REMARK 620 2 ASN A 840 OD1 130.4 REMARK 620 3 ASP A 853 OD2 79.7 69.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 307 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP B 304 O3G REMARK 620 2 ATP B 304 O2G 48.4 REMARK 620 3 ATP B 304 O3B 52.6 47.9 REMARK 620 4 ATP B 304 O1A 119.5 94.5 67.0 REMARK 620 5 ASP B 853 OD1 117.0 152.2 104.4 72.0 REMARK 620 6 ASP B 853 OD2 65.2 108.7 74.4 97.7 51.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 308 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP B 304 O3B REMARK 620 2 ASN B 840 OD1 136.8 REMARK 620 3 ASP B 853 OD2 80.4 76.8 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 304 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZYC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: WILD-TYPE IN REMARK 900 APO FORM. REMARK 900 RELATED ID: 1ZY4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: R794G REMARK 900 HYPERACTIVATING MUTANT IN APO FORM. REMARK 900 RELATED ID: 1ZY5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: R794G REMARK 900 HYPERACTIVATING MUTANT COMPLEXED WITH AMPPNP. REMARK 900 RELATED ID: 1ZXE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EIF2ALPHA PROTEIN KINASE GCN2: D835N REMARK 900 INACTIVATING MUTANT IN APO FORM. DBREF 1ZYD A 594 664 UNP P15442 GCN2_YEAST 525 595 DBREF 1ZYD B 594 664 UNP P15442 GCN2_YEAST 525 595 DBREF 1ZYD A 768 997 UNP P15442 GCN2_YEAST 699 928 DBREF 1ZYD B 768 997 UNP P15442 GCN2_YEAST 699 928 SEQADV 1ZYD SER A 592 UNP P15442 CLONING ARTIFACT SEQADV 1ZYD LEU A 593 UNP P15442 CLONING ARTIFACT SEQADV 1ZYD SER B 592 UNP P15442 CLONING ARTIFACT SEQADV 1ZYD LEU B 593 UNP P15442 CLONING ARTIFACT SEQRES 1 A 303 SER LEU ARG TYR ALA SER ASP PHE GLU GLU ILE ALA VAL SEQRES 2 A 303 LEU GLY GLN GLY ALA PHE GLY GLN VAL VAL LYS ALA ARG SEQRES 3 A 303 ASN ALA LEU ASP SER ARG TYR TYR ALA ILE LYS LYS ILE SEQRES 4 A 303 ARG HIS THR GLU GLU LYS LEU SER THR ILE LEU SER GLU SEQRES 5 A 303 VAL MET LEU LEU ALA SER LEU ASN HIS GLN TYR VAL VAL SEQRES 6 A 303 ARG TYR TYR ALA ALA TRP LEU GLU ARG ARG ASN PHE VAL SEQRES 7 A 303 LYS PRO MET THR ALA VAL LYS LYS LYS SER THR LEU PHE SEQRES 8 A 303 ILE GLN MET GLU TYR CYS GLU ASN ARG THR LEU TYR ASP SEQRES 9 A 303 LEU ILE HIS SER GLU ASN LEU ASN GLN GLN ARG ASP GLU SEQRES 10 A 303 TYR TRP ARG LEU PHE ARG GLN ILE LEU GLU ALA LEU SER SEQRES 11 A 303 TYR ILE HIS SER GLN GLY ILE ILE HIS ARG ASP LEU LYS SEQRES 12 A 303 PRO MET ASN ILE PHE ILE ASP GLU SER ARG ASN VAL LYS SEQRES 13 A 303 ILE GLY ASP PHE GLY LEU ALA LYS ASN VAL HIS ARG SER SEQRES 14 A 303 LEU ASP ILE LEU LYS LEU ASP SER GLN ASN LEU PRO GLY SEQRES 15 A 303 SER SER ASP ASN LEU THR SER ALA ILE GLY THR ALA MET SEQRES 16 A 303 TYR VAL ALA THR GLU VAL LEU ASP GLY THR GLY HIS TYR SEQRES 17 A 303 ASN GLU LYS ILE ASP MET TYR SER LEU GLY ILE ILE PHE SEQRES 18 A 303 PHE GLU MET ILE TYR PRO PHE SER THR GLY MET GLU ARG SEQRES 19 A 303 VAL ASN ILE LEU LYS LYS LEU ARG SER VAL SER ILE GLU SEQRES 20 A 303 PHE PRO PRO ASP PHE ASP ASP ASN LYS MET LYS VAL GLU SEQRES 21 A 303 LYS LYS ILE ILE ARG LEU LEU ILE ASP HIS ASP PRO ASN SEQRES 22 A 303 LYS ARG PRO GLY ALA ARG THR LEU LEU ASN SER GLY TRP SEQRES 23 A 303 LEU PRO VAL LYS HIS GLN ASP GLU VAL ILE LYS GLU ALA SEQRES 24 A 303 LEU LYS SER LEU SEQRES 1 B 303 SER LEU ARG TYR ALA SER ASP PHE GLU GLU ILE ALA VAL SEQRES 2 B 303 LEU GLY GLN GLY ALA PHE GLY GLN VAL VAL LYS ALA ARG SEQRES 3 B 303 ASN ALA LEU ASP SER ARG TYR TYR ALA ILE LYS LYS ILE SEQRES 4 B 303 ARG HIS THR GLU GLU LYS LEU SER THR ILE LEU SER GLU SEQRES 5 B 303 VAL MET LEU LEU ALA SER LEU ASN HIS GLN TYR VAL VAL SEQRES 6 B 303 ARG TYR TYR ALA ALA TRP LEU GLU ARG ARG ASN PHE VAL SEQRES 7 B 303 LYS PRO MET THR ALA VAL LYS LYS LYS SER THR LEU PHE SEQRES 8 B 303 ILE GLN MET GLU TYR CYS GLU ASN ARG THR LEU TYR ASP SEQRES 9 B 303 LEU ILE HIS SER GLU ASN LEU ASN GLN GLN ARG ASP GLU SEQRES 10 B 303 TYR TRP ARG LEU PHE ARG GLN ILE LEU GLU ALA LEU SER SEQRES 11 B 303 TYR ILE HIS SER GLN GLY ILE ILE HIS ARG ASP LEU LYS SEQRES 12 B 303 PRO MET ASN ILE PHE ILE ASP GLU SER ARG ASN VAL LYS SEQRES 13 B 303 ILE GLY ASP PHE GLY LEU ALA LYS ASN VAL HIS ARG SER SEQRES 14 B 303 LEU ASP ILE LEU LYS LEU ASP SER GLN ASN LEU PRO GLY SEQRES 15 B 303 SER SER ASP ASN LEU THR SER ALA ILE GLY THR ALA MET SEQRES 16 B 303 TYR VAL ALA THR GLU VAL LEU ASP GLY THR GLY HIS TYR SEQRES 17 B 303 ASN GLU LYS ILE ASP MET TYR SER LEU GLY ILE ILE PHE SEQRES 18 B 303 PHE GLU MET ILE TYR PRO PHE SER THR GLY MET GLU ARG SEQRES 19 B 303 VAL ASN ILE LEU LYS LYS LEU ARG SER VAL SER ILE GLU SEQRES 20 B 303 PHE PRO PRO ASP PHE ASP ASP ASN LYS MET LYS VAL GLU SEQRES 21 B 303 LYS LYS ILE ILE ARG LEU LEU ILE ASP HIS ASP PRO ASN SEQRES 22 B 303 LYS ARG PRO GLY ALA ARG THR LEU LEU ASN SER GLY TRP SEQRES 23 B 303 LEU PRO VAL LYS HIS GLN ASP GLU VAL ILE LYS GLU ALA SEQRES 24 B 303 LEU LYS SER LEU HET MG A 305 1 HET MG A 306 1 HET ATP A 303 31 HET MG B 307 1 HET MG B 308 1 HET ATP B 304 31 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 3 MG 4(MG 2+) FORMUL 5 ATP 2(C10 H16 N5 O13 P3) FORMUL 9 HOH *68(H2 O) HELIX 1 1 LEU A 593 ASP A 598 1 6 HELIX 2 2 GLU A 634 ALA A 648 1 15 HELIX 3 3 THR A 795 GLU A 803 1 9 HELIX 4 4 ASN A 804 GLN A 807 5 4 HELIX 5 5 GLN A 808 SER A 828 1 21 HELIX 6 6 LYS A 837 MET A 839 5 3 HELIX 7 7 GLY A 886 VAL A 891 5 6 HELIX 8 8 ALA A 892 ASP A 897 1 6 HELIX 9 9 GLU A 904 TYR A 920 1 17 HELIX 10 10 THR A 924 LEU A 932 1 9 HELIX 11 11 MET A 951 ILE A 962 1 12 HELIX 12 12 ASP A 965 ARG A 969 5 5 HELIX 13 13 GLY A 971 ASN A 977 1 7 HELIX 14 14 HIS A 985 LYS A 995 1 11 HELIX 15 15 LEU B 593 ASP B 598 1 6 HELIX 16 16 THR B 633 SER B 638 1 6 HELIX 17 17 ILE B 640 ALA B 648 1 9 HELIX 18 18 THR B 795 GLU B 803 1 9 HELIX 19 19 ASN B 804 GLN B 807 5 4 HELIX 20 20 GLN B 808 SER B 828 1 21 HELIX 21 21 LYS B 837 MET B 839 5 3 HELIX 22 22 GLY B 886 VAL B 891 5 6 HELIX 23 23 GLU B 904 TYR B 920 1 17 HELIX 24 24 THR B 924 LYS B 934 1 11 HELIX 25 25 MET B 951 ILE B 962 1 12 HELIX 26 26 ASP B 965 ARG B 969 5 5 HELIX 27 27 GLY B 971 ASN B 977 1 7 SHEET 1 A 5 PHE A 599 GLY A 606 0 SHEET 2 A 5 GLY A 611 ASN A 618 -1 O LYS A 615 N ALA A 603 SHEET 3 A 5 TYR A 624 THR A 633 -1 O LYS A 629 N GLN A 612 SHEET 4 A 5 LYS A 781 GLU A 789 -1 O LEU A 784 N ILE A 630 SHEET 5 A 5 TYR A 658 GLU A 664 -1 N TRP A 662 O PHE A 785 SHEET 1 B 2 ILE A 841 ILE A 843 0 SHEET 2 B 2 VAL A 849 ILE A 851 -1 O LYS A 850 N PHE A 842 SHEET 1 C 5 PHE B 599 GLN B 607 0 SHEET 2 C 5 GLY B 611 ASN B 618 -1 O LYS B 615 N ILE B 602 SHEET 3 C 5 TYR B 624 HIS B 632 -1 O LYS B 629 N GLN B 612 SHEET 4 C 5 SER B 782 GLU B 789 -1 O SER B 782 N HIS B 632 SHEET 5 C 5 TYR B 658 ARG B 768 -1 N GLU B 664 O THR B 783 SHEET 1 D 2 ILE B 841 ILE B 843 0 SHEET 2 D 2 VAL B 849 ILE B 851 -1 O LYS B 850 N PHE B 842 LINK O2G ATP A 303 MG MG A 305 1555 1555 2.77 LINK O3B ATP A 303 MG MG A 305 1555 1555 3.03 LINK O3G ATP A 303 MG MG A 305 1555 1555 2.86 LINK O1A ATP A 303 MG MG A 305 1555 1555 2.06 LINK O3B ATP A 303 MG MG A 306 1555 1555 2.39 LINK MG MG A 305 OD1 ASP A 853 1555 1555 2.68 LINK MG MG A 305 OD2 ASP A 853 1555 1555 2.53 LINK MG MG A 306 OD1 ASN A 840 1555 1555 2.22 LINK MG MG A 306 OD2 ASP A 853 1555 1555 2.45 LINK O3G ATP B 304 MG MG B 307 1555 1555 2.82 LINK O2G ATP B 304 MG MG B 307 1555 1555 3.12 LINK O3B ATP B 304 MG MG B 307 1555 1555 3.05 LINK O1A ATP B 304 MG MG B 307 1555 1555 2.10 LINK O3B ATP B 304 MG MG B 308 1555 1555 2.42 LINK MG MG B 307 OD1 ASP B 853 1555 1555 2.66 LINK MG MG B 307 OD2 ASP B 853 1555 1555 2.31 LINK MG MG B 308 OD1 ASN B 840 1555 1555 2.12 LINK MG MG B 308 OD2 ASP B 853 1555 1555 2.67 SITE 1 AC1 2 ATP A 303 ASP A 853 SITE 1 AC2 3 ATP A 303 ASN A 840 ASP A 853 SITE 1 AC3 2 ATP B 304 ASP B 853 SITE 1 AC4 3 ATP B 304 ASN B 840 ASP B 853 SITE 1 AC5 13 HOH A 7 HOH A 35 MG A 305 MG A 306 SITE 2 AC5 13 LEU A 605 VAL A 613 ALA A 626 GLU A 789 SITE 3 AC5 13 CYS A 791 ASP A 835 LYS A 837 ASN A 840 SITE 4 AC5 13 ASP A 853 SITE 1 AC6 12 HOH B 38 MG B 307 MG B 308 LEU B 605 SITE 2 AC6 12 VAL B 613 ALA B 626 GLU B 789 CYS B 791 SITE 3 AC6 12 ASP B 835 LYS B 837 ASN B 840 ASP B 853 CRYST1 82.110 175.210 47.570 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012179 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005707 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021022 0.00000